Cargando…
Referral, Genetic Counselling, and BRCA Testing in the Manitoba High-Grade Serous Ovarian Cancer Population, 2004–2019
SIMPLE SUMMARY: This study was performed to better understand rates and factors that influence patients in accepting a referral to genetics or testing for genes that predispose them to ovarian cancer (BRCA1/2). Using multiple provincial databases and registries, the study team looked at data from 94...
Autores principales: | Winchar, Kelcey, Lambert, Pascal, McManus, Kirk J., Chodirker, Bernie, Kean, Sarah, Serfas, Kim, Decker, Kathleen, Nachtigal, Mark W., Altman, Alon D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777417/ https://www.ncbi.nlm.nih.gov/pubmed/36547149 http://dx.doi.org/10.3390/curroncol29120735 |
Ejemplares similares
-
Paraneoplastic myositis secondary to poorly differentiated serous carcinoma of ovarian/tubal origin
por: Raizman, Zachary, et al.
Publicado: (2017) -
Cytotoxic capacity of a novel glycosylated antitumor ether lipid in chemotherapy-resistant high grade serous ovarian cancer in vitro and in vivo
por: Nachtigal, Mark W, et al.
Publicado: (2021) -
The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples
por: Penner-Goeke, Signe, et al.
Publicado: (2017) -
Manitoba
Publicado: (1896) -
Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas
por: Weren, Robbert D.A., et al.
Publicado: (2016)